Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion by Peng Huang, Jie Wang, Zongze Yu, Jiaan Lu, Zhou Sun, Zhigui Chen

Subjects: Get full text

Sulforaphane in alternative cancer chemotherapy: From carcinogenesis suppression to drug resistance reversal by Seyed Mohammad Doodmani, Payman Rahimzadeh, Najma Farahani, Seyedalireza Mirilavasani, Mina Alimohammadi, Noushin Nabavi, Elmira Alaei, Afshin Taheriazam, Maryam Abedi, Nadia Shafiee, Salman Daneshi, Mehrdad Hashemi

“…Conventional chemotherapy, despite its widespread use, has encountered obstacles such as the emergence of drug resistance. As a result, natural products have gained considerable attention as alternative therapies for cancer treatment. …”
Get full text

Rising prevalence and drug resistance of Corynebacterium striatum in lower respiratory tract infections by Wei Li, Mingyue Gao, Jinyan Yu

Subjects: Get full text

A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB by A. Vasquez, C. Mitnick, A.U. Nyaruhirira, C-Y. Chiang, C.R. Horsburgh

Subjects: “…tuberculosis, multi-drug resistant tuberculosis…”
Get full text

Identification of Mycobacterium tuberculosis and its Drug Resistance by Targeted Nanopore Sequencing Technology by Chen Tang, Feng Xu, Xiaoqun Zheng, Guangxin Xiang

“…Tuberculosis (TB) remains the leading cause of human mortality in infectious diseases. Drug-resistant TB, particularly multidrug-resistant TB and extensively drug-resistant TB, poses a pressing clinical and public health challenge. …”
Get full text

Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases by Ami B. Shah, Katarzyna A. Rejniak, Jana L. Gevertz

“…While chemoresistance in primary tumors is well-studied, much less is known about the influence of systemic chemotherapy on the development of drug resistance at metastatic sites. In this work, we use a hybrid spatial model of tumor response to a DNA damaging drug to study how the development of chemoresistance in micrometastases depends on the drug dosing schedule. …”
Get full text

Application of Nano-drug Delivery Technology in Overcoming Drug Resistance 
in Lung Cancer by Yingchun LU, Chunyu WANG, Bin LIU

Subjects: Get full text

Assessment of Patients Adherence to Oral Regimen of Drug-Resistant   Tuberculosis among Iraqi Patients by Noor Alaa Jasim, Manal Khalid Abdulridha, Ahmed Asmar Mankhy, Ahmed Hadi Tarish

Subjects: Get full text

Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens? by E. Pontali, M. Raviglione

“…In June 2024, WHO released ‘Key updates to the treatment of drug-resistant tuberculosis: rapid communication’, after the preliminary publication of results from two clinical trials: ‘BEAT-Tuberculosis’ and ‘endTB’. …”
Get full text

Nano‐gold micelles loaded Dox and Elacridar for reversing drug resistance of breast cancer by Liu‐Jing Wen, Yue‐Sheng Wang, Jie Zhang

“…Abstract The aim of this study was to provide a new effective carrier for rescuing the sensitivity of drug‐resistant in breast cancer cells. Nano‐gold micelles loaded with Dox and Elacridar (FP‐ssD@A‐E) were chemically synthesised. …”
Get full text

Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes by J. Limo, C. Pahe, I. Kathure, L. Ndungu, A. Mahihu, C. Mwashumbe, E. Mueni, H. Momanyi

“…BACKGROUND: Drug-resistant TB (DR-TB) remains a public health concern in Kenya, with an estimated 2,500 individuals acquiring DR-TB annually. …”
Get full text

Existence of multiple-stable equilibria for a multi-drug-resistant model of mycobacterium tuberculosis by Abba B. Gumel, Baojun Song

Subjects: “…key words and phrases. multi-drug-resistant tb…”
Get full text

Chromosomal genome assembly resolves drug resistance loci in the parasitic nematode Teladorsagia circumcincta. by Jennifer McIntyre, Alison Morrison, Kirsty Maitland, Duncan Berger, Daniel R G Price, Sam Dougan, Dionysis Grigoriadis, Alan Tracey, Nancy Holroyd, Katie Bull, Hannah Rose Vineer, Mike J Glover, Eric R Morgan, Alasdair J Nisbet, Tom N McNeilly, Yvonne Bartley, Neil Sargison, Dave Bartley, Matt Berriman, James A Cotton, Eileen Devaney, Roz Laing, Stephen R Doyle

“…To understand the genetics of drug resistance, we have generated a highly contiguous genome assembly for the UK T. circumcincta isolate, MTci2. …”
Get full text

Geospatial mapping of drug-resistant tuberculosis prevalence in Africa at national and sub-national levels by Alemneh Mekuriaw Liyew, Archie C.A. Clements, Fasil Wagnew, Beth Gilmour, Kefyalew Addis Alene

Subjects: “…Drug-resistant tuberculosis…”
Get full text

Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users. by Ahmed Reshid Tusho, Sheila Theresa Mokoboto-Zwane

“…Drug-resistant tuberculosis remains a persistent public health threat. …”
Get full text

Surgical Cryoablation of Drug Resistant Ventricular Tachycardia and Aneurysmectomy of Postinfarction Left Ventricular Aneurysm by Marek Pojar, Jan Harrer, Nedal Omran, Martin Vobornik

Get full text

The role of complement in tumor immune tolerance and drug resistance: a double-edged sword by Ronghui Yang, Di Fu, Di Fu, Aijun Liao

Subjects: Get full text

Molecular Mechanisms of Breast Cancer Drug Resistance and CRISPR/Cas9 Strategies to Overcome by Bashdar Mahmud Hussen, Bnar Saleh Ismael, Saman S. Abdulla, Noor Haval Jamal, Suhad Asad Mustafa, Zana Baqi Najmalddin, Mohammed Fatih Rasul

Subjects: Get full text

Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance by Peng Zhao, Shuangshuang Yin, Yuling Qiu, Changgang Sun, Haiyang Yu

“…Abstract Drug resistance is a common challenge in clinical tumor treatment. …”
Get full text

Biochar filtration of drug-resistant bacteria and active pharmaceutical ingredients to combat antimicrobial resistance by Paul-Enguerrand Fady, Alexandra K. Richardson, Leon P. Barron, A. James Mason, Roberto Volpe, Meredith R. Barr

“…Abstract Antimicrobial resistance (AMR) is a major cause of death worldwide, with 1.27 M direct deaths from bacterial drug-resistant infections as of 2019. Dissemination of multidrug-resistant (MDR) bacteria in the environment, in conjunction with pharmapollution by active pharmaceutical ingredients (APIs), create and foster an environmental reservoir of AMR. …”
Get full text